Natixis Advisors
SYRE icon

Natixis Advisors’s Spyre Therapeutics SYRE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,401
Closed -$265K 1694
2025
Q1
$265K Sell
16,401
-899
-5% -$14.5K ﹤0.01% 1565
2024
Q4
$403K Buy
+17,300
New +$403K ﹤0.01% 1515